NCT07062952View on ClinicalTrials.gov

Kidney-protective Intervention With Salt Substitute After Kidney Tumor Surgery: a Single-center Randomized Controlled Study

NARecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

April 24, 2025

Primary Completion Date

July 1, 2027

Study Completion Date

December 31, 2027

Conditions
Kidney TumorsCKDSalt SubstituteNephrectomyeGFR
Interventions
DIETARY_SUPPLEMENT

Salt substitute

Patient consume salt substitutes daily while strictly adhering to WHO-recommendedsalt intake levels for 1 year.Salt substitutes (potassium-enriched low-sodium salt, primarily NaCl and KCl) reduce sodium content versus regular salt

Trial Locations (1)

210000

RECRUITING

Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Nanjing

All Listed Sponsors
lead

Jinling Hospital, China

OTHER